Dow Up 1.63% Nasdaq Up 0.97%

Novo Nordisk A/S (NVO)

-NYSE
44.32 Oct 17, 4:00PM EDT
|Pre-Market : 44.30 Down 0.02 (0.05%) 9:02AM EDT - Nasdaq Real Time Price
Prev Close:44.32
Open:N/A
Bid:44.32 x 800
Ask:44.36 x 800
1y Target Est:49.37
Beta:0.8
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:33.04 - 49.11
Volume:0
Avg Vol (3m):1,073,760
Market Cap:116.51B
P/E (ttm):26.44
EPS (ttm):1.68
Div & Yield:0.61 (1.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVO 0.00%116.51B
LLY67.07B
PFE176.47B
SNY135.93B

Key Statistics

Forward P/E (1 yr):22.27
P/S (ttm):8.05
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.77
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback